Drawing for IQ CONNECT

USPTO serial 87095811

IQ CONNECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
NEHMER, JASON ROBERT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IQ CONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret C. McHugh

MARGARET C. MCHUGH KILPATRICK TOWNSEND & STOCKTON LLP1100 PEACHTREE STREET, SUITE 2800Mailstop: IP Docketing - 22ATLANTA, GA 30309

Goods and services

ClassDescriptionStatusFirst use
042providing temporary online use of non-downloadable software for secure messaging and notification in connection with patient tests and analysis, patient records, medical records, content, documents, and images, for use in the fields of cancer diagnostics and prognostics; providing temporary use of non-downloadable software for use in collecting, managing, analyzing, storing, sharing, and comparing medical information, patient records, patient laboratory orders, patient tests and analysis, and reporting on the same; all of the foregoing for use in the field of cancer diagnostics and prognosticsACTIVE
044Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Providing medical information to medical professionals, namely oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; medical reporting services, namely, compilation of medical reports in the field of disease classification for use by oncologists and treating physicians for cancer patients; providing medical information, consultancy and advisory services in the field of disease classification for oncologists and treating physicians; health care consultancy services in the nature of oncology testing and diagnostics; medical data analysis, in the nature of analysis of tissue and bodily fluids for oncologists and treating physicians for cancer patients; patient medical data analysis in the nature of analysis of tissue and bodily fluids for oncologists and treating physicians of cancer patients; Health care services, namely, providing a database of diseases and the collection of disease data and information all for oncologists and treating physicians for diagnostic and prognostics purposes in the field of cancer; Health care services, namely, providing a database in the field of patient diagnostic molecular, biomarker, genomic medicine, and clinical data including laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for diagnostic and prognostics purposes for oncologists and treating physicians; Predictive modeling of data in the fields of medicine and healthcare for medical diagnostic and surveillance purposes; Patient outcome analysis services, namely, providing on-line record analysis services designed to provide medical professionals and patients with custom tailored information about the range of possible diagnoses, treatments and therapies and evaluating patient records, disease markers to provide patients with information about possible diagnoses, treatments and therapies; all of the foregoing for use in the field of cancer diagnostics and prognosticsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 24, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 24, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2019EX1GSOU EXTENSION 1 GRANTED
Jul 16, 2019EXT1SOU EXTENSION 1 FILED
Jul 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 18, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 18, 2017ALIEASSIGNED TO LIE
Apr 3, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 3, 2017GNSLLETTER OF SUSPENSION E-MAILED
Apr 3, 2017CNSLSUSPENSION LETTER WRITTEN
Mar 18, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2016DOCKASSIGNED TO EXAMINER
Jul 12, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance